Comparing two pain management techniques after knee surgery
Comparative Study Between Ultrasound-Guided IPACK Block (Interspace Between the Popliteal Artery and the Posterior Capsule of the Knee) with Adductor Canal Block Versus Adductor Canal Block Alone for Postoperative Pain Management in Total Knee Arthroplasty
This study is testing whether using a combination of two pain management techniques after knee surgery can help patients feel less pain and wait longer before needing extra pain relief compared to using just one technique.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Enrollment | 60 (estimated) |
| Ages | 20 Years to 60 Years |
| Sex | All |
| Sponsor | Ain Shams University Academic / other |
| Locations | 1 site (Cairo) |
| Trial ID | NCT06783712 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of combining an ultrasound-guided IPACK block with an adductor canal block versus using the adductor canal block alone for managing postoperative pain in patients undergoing total knee arthroplasty. Patients will be assessed preoperatively and monitored during surgery to ensure proper anesthesia and pain management. The primary outcome will be the time until the first dose of rescue analgesia is needed, along with pain assessment using a numerical rating scale (NRS).
Who should consider this trial
Good fit: Ideal candidates are patients scheduled for total knee arthroplasty who meet the inclusion criteria.
Not a fit: Patients with a history of coagulopathy, neuromuscular disorders, or those who refuse consent may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved pain management and faster recovery for patients after knee surgery.
How similar studies have performed: Previous studies have shown promising results with similar pain management techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: - Exclusion Criteria: * The patient refusal to give written consent. * Previously known allergy to one of the drugs being used in the study. * Physical status: ASA grades more than III * History or evidence of coagulopathy, use of anti-coagulant or anti-platelet therapy. * Patients with neuromuscular disorders * Injection site infection.
Where this trial is running
Cairo
- Ain Shams University — Cairo, Egypt (Recruiting)
Study contacts
- Principal investigator: Hager Talal Mohamed, MBBCH — Anesthesia Resident Ain Shams University
- Study coordinator: Hager Talal Mohamed, MBBCH
- Email: hager.talal5@gmail.com
- Phone: +201119050190
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.